Clinical Trial Update: A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

View source ↗

Summary

This update reports the long-term follow-up of patients who achieved complete clearance of actinic keratosis lesions at Day 57 in the PEP005-028 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Status: COMPLETED